Should ketamine be used to treat depression?
17 August, 2016 by Adam FloranceAntipodean researchers are launching the largest randomised control trial into the use of ketamine for patients suffering from long-term depression.
Does evolution play a part in where we develop cancer?
11 August, 2016Scientists have suggested that the reasons people and animals develop cancer in some organs but not in others may have more to do with evolution than any lifestyle or genetic factors.
NSW's most outstanding cancer researchers acknowledged
09 August, 2016The 2016 NSW Premier's Awards for Outstanding Cancer Research were held as part of an annual gala dinner that celebrates excellence and innovation in cancer research.
Liquid biopsies: testing times ahead for neuroblastoma
05 August, 2016 by Professor Murray Norris*Imagine a future where simple blood tests provide an efficient, painless and non-invasive way to track changes in cancer patients and guide treatment.
Updated guidelines for treating heart attack symptoms
02 August, 2016 by Adam FloranceAcross Australia and New Zealand, mortality and morbidity rates remain significant among patients presenting with acute coronary syndromes (ACS).
Tumour-derived exosomes pave way for 'liquid biopsy'
01 August, 2016Innovative research into the role of tumour fragments in the bloodstream could contribute to the development of a blood test for cancer, according to Perth researchers.
Macquarie brings proteomics expertise to Cancer Moonshot program
29 July, 2016Macquarie University has signed an MoU with the US National Cancer Institute, which will see the organisations work together on the Cancer Moonshot initiative to help drive further momentum into critical cancer research.
Cortisol inhibition could treat Alzheimer's
29 July, 2016Separate studies from Actinogen Medical and AIBL suggest that excess cortisol production is linked with the development of Alzheimer's disease.
An autoimmunity primer
22 July, 2016Autoimmunity occurs when the adaptive immune system's process of self-tolerance fails, rendering it unable to distinguish between self- and nonself-antigens — potentially leading to autoimmune diseases.
Could cannabis treat skin cancer?
06 July, 2016The University of Canberra and Cann Pharmaceutical are teaming up on a million-dollar, medical-grade cannabis therapy trial for melanoma patients.
NHMRC funding for infectious disease research and more
01 July, 2016The NHMRC has announced 21 new grants, handing out almost $19 million of the $850 million the council will deliver to support health and medical research in Australia this year.
Does continuous mobility measurement help Parkinson's patients?
24 June, 2016Global Kinetics Corporation and the National Parkinson Foundation have announced a clinical research collaboration to study the impact of continuous objective measurement of movement in Parkinson's disease patients using Global Kinetics' PKG Movement Recording System.
Preventing breast cancer in high-risk women
22 June, 2016The drug denosumab may have the potential to prevent breast cancer in women carrying a faulty BRCA1 gene. If confirmed in clinical studies, this would provide a non-surgical option for breast cancer prevention in women with an elevated genetic risk.
Radical MS chemo
16 June, 2016 by Adam FloranceA new Canadian trial may have found a radical way to halt the acceleration of multiple sclerosis symptoms, but even its authors are wary about its potential dangers.
CSL and QIMR Berghofer partner on translational research
15 June, 2016CSL has announced a five-year agreement with QIMR Berghofer to help turn the institute's scientific discoveries into innovative new medical technologies.
